Agomelatine

Educational summary, not a formulary. Dosing is quoted from the Makindo chapters and topics site. The other sections are draft summaries not yet checked line by line against the BNF or SPC. Check dose, indication, interactions and monitoring in the BNF entry for Agomelatine and local guidelines before prescribing.

Antidepressant

Mechanism

Melatonin agonist and 5-HT2C antagonist.

Uses

Major depression.

Dosing

No dose is given in the chapters. See the BNF.

Side effects

Nausea, headache, raised transaminases.

Interactions

Fluvoxamine and ciprofloxacin raise levels.

Contraindications and cautions

Hepatic impairment

Monitoring

LFT

Pregnancy and breastfeeding

Avoid

Renal and hepatic impairment

Contraindicated in hepatic impairment

Overdose and reversal

Supportive

Special advice

LFT at baseline, 3, 6, 12 and 24 weeks.

More from the textbook: uses, cautions and other points
Where it is discussed in the book